^Chen LS، Lo CF، Numann R، Cuddy M (يوليو 1997). "Characterization of the human and rat phospholemman (PLM) cDNAs and localization of the human PLM gene to chromosome 19q13.1". Genomics. ج. 41 ع. 3: 435–43. DOI:10.1006/geno.1997.4665. PMID:9169143.
Neumann J، Maas R، Bokník P، وآخرون (1999). "Pharmacological characterization of protein phosphatase activities in preparations from failing human hearts". J. Pharmacol. Exp. Ther. ج. 289 ع. 1: 188–93. PMID:10087003.
Mounsey JP، John JE، Helmke SM، وآخرون (2000). "Phospholemman is a substrate for myotonic dystrophy protein kinase". J. Biol. Chem. ج. 275 ع. 30: 23362–7. DOI:10.1074/jbc.M000899200. PMID:10811636.{{استشهاد بدورية محكمة}}: صيانة الاستشهاد: دوي مجاني غير معلم (link)
Sweadner KJ، Rael E (2001). "The FXYD gene family of small ion transport regulators or channels: cDNA sequence, protein signature sequence, and expression". Genomics. ج. 68 ع. 1: 41–56. DOI:10.1006/geno.2000.6274. PMID:10950925.
Deng V، Matagne V، Banine F، وآخرون (2007). "FXYD1 is an MeCP2 target gene overexpressed in the brains of Rett syndrome patients and Mecp2-null mice". Hum. Mol. Genet. ج. 16 ع. 6: 640–50. DOI:10.1093/hmg/ddm007. PMID:17309881.